Showing results (41-50 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1992
Effects of nitrous oxide on psychological performanceB Tiplady, W A Sinclair, L M MorrisonPsychopharmacology Bulletin|November 19, 2003
The history of valproate in clinical neuroscienceThomas R HenryPsychopharmacology Bulletin|January 1, 1992
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depressionE Frank, J M Perel, A G Mallinger, et al.Psychopharmacology Bulletin|January 1, 1992
Are patients who are intolerant to one SSRI intolerant to another?W A Brown, W HarrisonPsychopharmacology Bulletin|January 1, 1992
Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neuronsG A Gudelsky, E E Nwajei, K Defife, et al.Psychopharmacology Bulletin|January 1, 1992
Effect of anticholinergics on positive and negative symptoms in schizophreniaR Tandon, J R DeQuardo, J Goodson, et al.Psychopharmacology Bulletin|January 1, 1992
Continuation treatment with adjunctive imipramine in schizophreniaS G Siris, P C Bermanzohn, S E Mason, et al.Psychopharmacology Bulletin|December 10, 2021
A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian ScenarioJisha M Lucca, Fatima M Al-Turaifi, Al-Mubayedh Safyah, et al.Psychopharmacology Bulletin|December 10, 2021
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking AgentsShaina Schwartz, Lauren Dinkla, Jocelyn Pullen, et al.Psychopharmacology Bulletin|December 10, 2021
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive DisorderM S Zastrozhin, A V Efimova, VYu Skryabin, et al.Pageof 128